← Leaderboards
Benjamin Robert Morehouse
Dana-Farber Cancer Inst
$506,359
Attributed
$506,359
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $379.8K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$506,359 · 2
By mechanism
R35$379,823 · 1
F32$126,536 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Piotr Sicinski$42,703,610
- Michael J Eck$25,871,961
- Kasisomayajula Viswanath$37,155,095
- Felipe Diaz-Griffero$13,396,653
- Michael A Calderwood$3,414,668
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsStimulator Of Interferon GenesInfectionPathogenSecond Messenger SystemsSignal TransductionEnzymesImmuneNatural ImmunityOrganismPeriodicityResponseBiochemicalSignal PathwayCyclic GmpDinucleoside PhosphatesBacteriaHomologous GeneInnate Immune SystemMalignant NeoplasmsNucleotidesCellular StressAutoimmune DiseasesViral
Grant awards (3)
Defining the mechanisms that drive novel cyclic nucleotide signaling in immune defense$379,823
R35 · FY2025 · GM · contact PI
Mechanism of activation of a new cGAS-like enzyme in humans$65,310
F32 · FY2020 · GM · contact PI
Mechanism of activation of a new cGAS-like enzyme in humans$61,226
F32 · FY2019 · GM · contact PI